Schrodinger, Inc. balance sheet
At the end of fiscal 2025, Schrodinger, Inc. had total assets of $726m, total liabilities of $362m and shareholders' equity of $364m. It held $231m in cash against $0 of debt: net cash of $231m.
Balance sheet
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26 | 202 | 120 | 90 | 155 | 147 | 231 | 288 |
| Receivables | 19 | 31 | 32 | 56 | 66 | 236 | 83 | 21 |
| Total current assets | 119 | 683 | 625 | 534 | 568 | 635 | 519 | 470 |
| Goodwill | — | — | 0 | 5 | 5 | 5 | 5 | 5 |
| Total assets | 155 | 746 | 756 | 689 | 803 | 823 | 726 | 640 |
| Accounts payable | 4 | 8 | 8 | 9 | 17 | 11 | 11 | 10 |
| Deferred revenue (current) | 25 | 45 | 55 | 58 | 56 | 112 | 113 | 105 |
| Total current liabilities | 45 | 73 | 91 | 109 | 134 | 192 | 189 | 174 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 57 | 122 | 199 | 241 | 254 | 402 | 362 | 311 |
| Shareholders' equity | −93 | 624 | 557 | 448 | 549 | 421 | 364 | 329 |
| Non-controlling interests and other (assets − liabilities − equity) | 192 | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −26 | −202 | −120 | −90 | −155 | −147 | −231 | −288 |
| Shares outstanding | 61m | 61m | 62m | 62m | 63m | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 13 | 236 | 20 | 10 | 29 | 83 | 27 | 21 |
| Total current assets | 456 | 635 | 571 | 514 | 472 | 519 | 464 | 470 |
| Goodwill | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Total assets | 669 | 823 | 743 | 688 | 654 | 726 | 634 | 640 |
| Accounts payable | 11 | 11 | 12 | 9 | 9 | 11 | 12 | 10 |
| Deferred revenue (current) | 42 | 112 | 105 | 95 | 82 | 113 | 103 | 105 |
| Total current liabilities | 111 | 192 | 165 | 156 | 145 | 189 | 170 | 174 |
| Total liabilities | 220 | 402 | 370 | 345 | 332 | 362 | 321 | 311 |
| Shareholders' equity | 449 | 421 | 374 | 343 | 321 | 364 | 314 | 329 |
Compare with peers
- Mesa Laboratories Inc balance sheet
- Maravai Lifesciences Holdings, Inc. balance sheet
- Fulgent Genetics, Inc. balance sheet
- Cytek Biosciences, Inc. balance sheet
- Castle Biosciences Inc balance sheet
Head to head: MLAB vs SDGRMRVI vs SDGRFLGT vs SDGRCSTL vs SDGR
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies